Fidelity International’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.1M Buy
38,034
+35,195
+1,240% +$9.53M 0.01% 584
2025
Q4
$712K Sell
2,839
-2,102
-43% -$558K ﹤0.01% 863
2025
Q3
$1.42M Sell
4,941
-308,826
-98% -$82.7M ﹤0.01% 761
2025
Q2
$82.4M Sell
313,767
-68,308
-18% -$16.6M 0.07% 253
2025
Q1
$88.9M Sell
382,075
-369
-0.1% -$89.5K 0.08% 237
2024
Q4
$87.7M Sell
382,444
-9,923
-3% -$2.28M 0.08% 235
2024
Q3
$87.7M Sell
392,367
-5,527
-1% -$1.21M 0.08% 248
2024
Q2
$81M Buy
397,894
+7,603
+2% +$1.55M 0.08% 244
2024
Q1
$85.3M Sell
390,291
-2,649
-0.7% -$584K 0.08% 245
2023
Q4
$89.3M Sell
392,940
-13,209
-3% -$2.77M 0.09% 234
2023
Q3
$81.7M Sell
406,149
-65,765
-14% -$13.9M 0.1% 228
2023
Q2
$97.8M Sell
471,914
-58,127
-11% -$11.3M 0.11% 210
2023
Q1
$104M Buy
530,041
+31,329
+6% +$6.45M 0.12% 187
2022
Q4
$101M Buy
498,712
+213,504
+75% +$41.7M 0.12% 193
2022
Q3
$50.2M Buy
+285,208
New +$58.4M 0.06% 285
2021
Q2
Sell
-5
Closed -$1K 981
2021
Q1
$1K Hold
5
﹤0.01% 919
2020
Q4
$1K Hold
5
﹤0.01% 887
2020
Q3
$1K Buy
+5
New +$792 ﹤0.01% 877
2020
Q1
Sell
-3
Closed -$1K 909
2019
Q4
$1K Sell
3
-21,114
-100% -$3.05M ﹤0.01% 896
2019
Q3
$3.05M Sell
21,117
-12,222
-37% -$1.78M ﹤0.01% 588
2019
Q2
$4.95M Sell
33,339
-1,004
-3% -$140K 0.01% 531
2019
Q1
$4.51M Sell
34,343
-12,489
-27% -$1.54M 0.01% 520
2018
Q4
$5.08M Sell
46,832
-34,056
-42% -$4.56M 0.01% 512
2018
Q3
$12.1M Sell
80,888
-17,908
-18% -$2.72M 0.02% 462
2018
Q2
$15.2M Buy
98,796
+26,789
+37% +$4.04M 0.02% 438
2018
Q1
$10M Buy
72,007
+16,836
+31% +$2.47M 0.03% 355
2017
Q4
$7.56M Buy
55,171
+5,658
+11% +$748K 0.02% 378
2017
Q3
$6.42M Buy
+49,513
New +$6.6M 0.02% 379

Other funds holding LH

Fidelity International's LH Position: Q1 2026 in Review

Fidelity International increased its Labcorp (LH) stake by 1,240% in Q1 2026, buying an estimated $9.53M and bringing the position to 38,034 shares worth $10.1M. The position accounts for 0.01% of the portfolio, ranked #584.

Fidelity International first reported a position in LH in Q3 2017 and has held it in 28 quarters since. The position peaked at $104M in Q1 2023. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Fidelity International held 38,034 shares of Labcorp worth $10.1M as of Q1 2026.
  • Fidelity International bought 35,195 Labcorp shares in Q1 2026, an estimated $9.53M.
  • Labcorp made up 0.01% of Fidelity International's portfolio in Q1 2026, its #584 holding.
  • Fidelity International first reported a position in Labcorp in Q3 2017 and has held it in 28 quarters since.
  • Fidelity International's Labcorp position peaked at $104M in Q1 2023.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Fidelity International's 13F filing for Q1 2026, filed 15 May 2026.